Healthcare -
Biotechnology - NASDAQ - US
$ 0.5326
-9.44 %
$ 44.1 M
Market Cap
-0.45
P/E
CASH FLOW STATEMENT
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Adicet Bio, Inc.
| Net Income | -117 M |
| Depreciation & Amortization | 4.8 M |
| Capital Expenditures | -1.12 M |
| Stock-Based Compensation | 22.2 M |
| Change in Working Capital | 0 |
| Others | -8.92 M |
| Free Cash Flow | -93.5 M |
Cash Flow
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Jun-2017 | Jun-2016 | Jun-2015 | Jun-2014 | Jun-2013 | Jun-2012 | Jun-2011 | Jun-2010 | Jun-2009 | Jun-2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||||||||||
| Net Income | (117.1) | (142.7) | (69.8) | (62.0) | (36.7) | (28.1) | (9.3) | (33.8) | 33.5 | 29.0 | 22.3 | 22.3 | 17.0 | 9.0 | 6.6 | 8.6 | 13.5 |
| Depreciation & Amortization | 4.8 | 6.1 | 2.6 | 1.5 | 1.2 | 1.2 | 1.2 | 5 K | 11.8 | 8.1 | 6.9 | 6.9 | 6.9 | 5.5 | 2.8 | 1.9 | 2.4 |
| Deferred Income Tax | 0 | 0 | 0 | 1.2 | 3.2 | 0 | 0 | 18 K | 1.9 | 3.1 | 2.6 | 2.6 | 1.8 | (0.7) | (0.8) | 0.2 | (121.5) |
| Stock Based Compensation | 22.2 | 20.3 | 17.1 | 12.5 | 5.3 | 1.2 | 2.5 | 0.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Operating Activities | (2.3) | 22.3 | 2.6 | 1.7 | (1.0) | (2.5) | (4.5) | 16.6 | (70.9) | (47.7) | (18.3) | (12.9) | (8.1) | 3.2 | (21.0) | (134.4) | (1.7) |
| Change in Working Capital | 0 | 0.3 | 2.7 | (6.1) | (13.5) | 0.3 | (8.0) | 4.3 | 27.5 | 29.4 | 10.1 | 2.9 | (5.5) | (3.8) | (4.1) | 144.7 | 121.5 |
| Cash From Operations | (92.4) | (93.7) | (44.8) | (51.1) | (41.6) | (27.9) | (18.2) | (11.6) | 8.3 | 25.1 | 25.5 | 23.7 | 13.3 | 14.0 | (15.5) | 22.5 | 15.4 |
| INVESTING CASH FLOW | |||||||||||||||||
| Capital Expenditures | (1.1) | (4.5) | (16.8) | (13.0) | (1.0) | (1.1) | (0.9) | 44 K | (0.6) | (1.1) | (1.0) | (1.0) | (1.1) | (5.4) | (4.0) | (0.6) | (1.2) |
| Other Items | (118.1) | 0 | 0 | 10.2 | 116.2 | (46.9) | (15.2) | 0 | (8.4) | (84.8) | (1.8) | 34 K | (0.7) | (63.8) | (2.1) | (3.5) | 2.6 |
| Cash From Investing Activities | (119.2) | (4.5) | (16.8) | (2.8) | 115.2 | (47.9) | (16.1) | 44 K | (9.0) | (85.9) | (2.8) | (1.1) | (1.8) | (69.2) | (6.1) | (4.1) | 1.4 |
| FINANCING CASH FLOW | |||||||||||||||||
| Common Stock Repurchased | 0 | (0.1) | 0 | 0 | 0 | 0 | 0 | (55.7) | 0 | (34.0) | (42.9) | (33.2) | (24.9) | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0.4 | 0.2 | (1.9) | 4.6 | 0.3 | 76.9 | 11.0 | 0 | 0 | 70.5 | (14.3) | (14.3) | (15.3) | 50.0 | (2.4) | (4.3) | (6.0) |
| Cash From Financing Activities | 111.3 | 0.2 | 41.5 | 242.7 | 0.3 | 76.9 | 11.0 | 64.9 | 0 | 70.5 | (14.3) | (14.3) | (15.3) | 50.0 | (2.4) | (4.3) | (6.0) |
| CHANGE IN CASH | |||||||||||||||||
| Net Change In Cash | (100.3) | (97.9) | (20.0) | 188.8 | 74.0 | 1.1 | (23.2) | 30.5 | (8.9) | 9.7 | 8.4 | 8.4 | (3.8) | (2.2) | (26.9) | 11.2 | 14.2 |
| FREE CASH FLOW | |||||||||||||||||
| Free Cash Flow | (93.5) | (98.2) | (61.5) | (64.1) | (42.5) | (29.0) | (19.1) | (11.6) | 7.7 | 23.9 | 24.5 | 22.7 | 12.2 | 8.6 | (19.5) | 22.0 | 14.2 |